SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-030485
Filing Date
2023-11-07
Accepted
2023-11-07 07:25:51
Documents
15
Period of Report
2023-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K zvra20230816_8k.htm   iXBRL 8-K 32623
2 EXHIBIT 99.1 ex_561763.htm EX-99.1 191688
7 zvrapic.jpg GRAPHIC 5705
  Complete submission text file 0001437749-23-030485.txt   387257

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zvra-20231107.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zvra-20231107_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20231107_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20231107_pre.xml EX-101.PRE 11585
9 EXTRACTED XBRL INSTANCE DOCUMENT zvra20230816_8k_htm.xml XML 2600
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 231381559
SIC: 2834 Pharmaceutical Preparations